Showing results (1331-1340 of 3,295) with videos related to
Sort By:
Pageof 330
Metabolic Brain Disease|September 30, 2022
AMPK-dependent autophagy activation and alpha-Synuclein clearance: a putative mechanism behind alpha-mangostin's neuroprotection in a rotenone-induced mouse model of Parkinson's diseasePathik Parekh, Nishant Sharma, Monika Sharma, et al.Metabolic Brain Disease|September 23, 2022
Treatments against Polymorphosal discrepancies in Glioblastoma MultiformeNobendu Mukerjee, Swastika Maitra, Subhradeep Roy, et al.Metabolic Brain Disease|September 26, 2022
Vitamin D3 supplementation ameliorates cognitive impairment and alters neurodegenerative and inflammatory markers in scopolamine induced rat modelParmi Patel, Jigna ShahMetabolic Brain Disease|January 26, 2021
Computational exploration of vicine - an alkaloid glycoside mediated pathological hallmark of adenosine kinase to promote neurological disorderSathishKumar Paramashivam, Suganthana Balasubramaniam, Kannan Narayanan DhiraviamMetabolic Brain Disease|January 28, 2021
The orphan nuclear receptor Nurr1 agonist amodiaquine mediates neuroprotective effects in 6-OHDA Parkinson's disease animal model by enhancing the phosphorylation of P38 mitogen-activated kinase but not PI3K/AKT signaling pathwayPiniel Alphayo Kambey, Ma Chengcheng, Guo Xiaoxiao, et al.Metabolic Brain Disease|January 19, 2021
Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of actionYane Costa Chaves, Karina Genaro, José Alexandre Crippa, et al.Metabolic Brain Disease|November 12, 2021
Circ_0057583 facilitates brain microvascular endothelial cell injury through modulating miR-204-5p/NR4A1 axisXiaoyu Wang, Lili Liu, Lei Zhang, et al.Metabolic Brain Disease|November 12, 2021
Chronic and progressive dopaminergic neuronal death in substantia nigra associates with a decrease in serum levels of glucose and free fatty acids, the role of interlokin-1 betaAli Sarbazi-Golezari, Hashem Haghdoost-YazdiMetabolic Brain Disease|March 4, 2021
Individuals with SATB2-associated syndrome with and without autism have a recognizable metabolic profile and distinctive cellular energy metabolism alterationsYuri A Zarate, Jenny-Li Örsell, Katherine Bosanko, et al.Metabolic Brain Disease|February 2, 2021
Neuronal activity regulated pentraxin (narp) and GluA4 subunit of AMPA receptor may be targets for fluoxetine modulationIsabella A Heinrich, Andiara E Freitas, Ingrid A V Wolin, et al.Pageof 330